FrancophonIA/ELRC3.0 huggingface dataset:
English: For the full list of side effects and restrictions with Somavert, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja prilikom primjene lijeka Somavert potražite u uputi o lijeku.
English: In adults, rather than gaining height, overproduction of growth hormone leads to acromegaly, with overgrowth of bone, swelling of soft tissue (such as the hands and feet),
Croatian: akromegalija koje se očituje prekomjernim rastom kostiju, oticanjem mekog tkiva (na primjer, ruke i stopala), bolešću srca i drugim poremećajima.
English: How is Somavert used?
Croatian: Kako se Somavert primjenjuje?
English: ATCvet code: QI04AA02.
Croatian: ATCvet kôd: QI04AA02.
English: The entire content of the bottle should be used immediately after broaching and during the same procedure.
Croatian: Čitav sadržaj bočice treba upotrijebiti neposredno nakon otvaranja i tijekom istog postupka.
English: The level of efficacy for other species may differ from that observed in sheep.
Croatian: Razina učinkovitosti kod drugih vrsta može se razlikovati od one uočene kod ovaca.
English: Date of last renewal: 07/01/2016
Croatian: Datum posljednjeg odobrenja: 07/01/2016
English: a) the administration of the product to animals will interfere with the implementation of national programme for the diagnosis, control or eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals.
Croatian: a) će primjena proizvoda na životinjama interferirati s provedbom nacionalnih programa za otkrivanje, kontrolu ili iskorjenjivanje bolesti životinja ili će prouzročiti poteškoće u certificiranju odsutnosti zaraze u živih životinja ili hrani ili drugim proizvodima dobivenim od tretiranih životinja.
English: Avoid multiple vial broaching.
Croatian: Izbjegavajte višestruko probijanje čepa.
English: Off-white or pink liquid.
Croatian: Sivkasto bijela ili ružičasta tekućina.
English: The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision.
Croatian: Nositelj ovog odobrenja za stavljanje VMP u promet mora obavijestiti Europsku komisiju o planovima za stavljanje u promet medicinskog proizvoda odobrenog ovom odlukom.
English: Can be used during pregnancy.
Croatian: Može se primjenjivati tijekom graviditeta.
English: Pregnancy: Can be used during pregnancy.
Croatian: Graviditet: Može se primjenjivati tijekom graviditeta.
English: 1st injection: from 1.5 months of age.
Croatian: Prva injekcija: nakon navršenih 1,5 mjeseci starosti.
English: Avoid bubble formation, as this can be irritating at the site of injection.
Croatian: Izbjegavajte formiranje mjehurića jer oni mogu iritirati mjesto ubrizgavanja.
English: Shelf life of the veterinary medicinal product as packaged for sale: 1 year.
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kada je zapakiran za prodaju: 1 godina.
English: *(Cycling value (Ct) ≥ 36 by a validated RT-PCR method, indicating no presence of viral genome).
Croatian: *(Vrijednost cikliranja (Ct) ≥ 36 potvrdnom metodom RT-PCR, koja ukazuje da nema viralnog genoma).
English: The excipients, including adjuvants, listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product.
Croatian: Pomoćne tvari (uključujući adjuvanse) navedene u dijelu 6.1 SPC su ili dozvoljene tvari za koje je u tablici 1, Dodatka Uredbe Komisije (EU) br. 37/2010 navedeno da određivanje MRL nije nužno, ili se smatra da se na njih ne primjenjuju odredbe Uredbe (EK) br. 470/2009 kada se primjenjuju u tim veterinarsko-medicinskim proizvodima.
English: Incompatibilities: Do not mix with any other veterinary medicinal products.
Croatian: Inkompatibilnosti: Ne miješajte s drugim veterinarsko-medicinskim proizvodima.
English: SPECIAL STORAGE CONDITIONS Store and transport refrigerated .
Croatian: 11. POSEBNI UVJETI ČUVANJA Čuvati i prevoziti na hladnom.
English: Duration of immunity: 12 months after completion of the primary vaccination scheme.
Croatian: Trajanje imunosti: 12 mjeseci nakon završetka sheme primarnog cijepljenja.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Croatian: Ako zamijetite bilo koju ozbiljnu nuspojavu ili druge nuspojave koje nisu opisane u uputi o VMP ili mislite da veterinarsko-medicinski proizvod ne djeluje, molimo obavijestite svog veterinara.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e) za vrijeme trajanja tretmana) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
English: The use of this veterinary medicinal product is only allowed under the particular conditions established by European Community legislation on the control of Bluetongue.
Croatian: Primjena ovog veterinarsko-medicinskog proizvoda dopuštena je samo pod određenim uvjetima koje utvrđuju propisi Europske unije o kontroli bolesti plavog jezika.
English: No information is available on the use of the vaccine in seropositive animals including those with maternally derived antibodies.
Croatian: Nisu dostupne informacije o primjeni cjepiva na seropozitivnim životinjama, uključujući one kod kojih su antitijela prenesena s majke.
English: High density polyethylene (HDPE) vials of 20, 100 or 240 ml with chlorobutyl elastomer stopper and aluminium seal containing 10, 50 or 120 doses of vaccine.
Croatian: Bočice od poletilena visoke gustoće (HDPE) od 20, 100 ili 240 ml sa čepom od klorobutil elastomera i aluminijskim poklopcem, koje sadrže 10, 50 ili 120 doza cjepiva.
English: Water for injections.
Croatian: Voda za injekcije
English: Shelf life after first opening the immediate packaging: use immediately after broaching.
Croatian: Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: upotrijebiti neposredno poslije otvaranja.
English: Any revaccination scheme should be agreed by the Competent Authority or by the responsible veterinarian, taking into account the local epidemiological situation.
Croatian: Shemu revakcinacije treba usuglasiti s nadležnim tijelom ili odgovornim veterinarom, uzimajući u obzir lokalnu epidemiološku situaciju.
English: Onset of immunity: 21 days after completion of the primary vaccination scheme.
Croatian: Početak imunosti: 21 dan nakon završetka sheme primarnog cijepljenja.
English: Do not mix with any other veterinary medicinal product.
Croatian: Ne miješajte s drugim veterinarsko-medicinskim proizvodima.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Preprinted carton box 1 x 20 ml, 1 x 100 ml and 1 x 240 ml
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Unaprijed otisnuta kartonska kutija 1 x 20 ml, 1 x 100 ml i 1 x 240 ml
English: *Relative Potency by a mice potency test compared to a reference vaccine that was shown efficacious in sheep.
Croatian: *Relativna potentnost dobivena testiranjem na miševima u usporedbi s referentnim cjepivom koje se pokazalo učinkovitim kod ovaca.
English: Pharmacotherapeutic group: Inactivated viral vaccines for sheep, Bluetongue virus.
Croatian: Farmakoterapijska skupina: inaktivirana virusna cjepiva za ovce, virus bolesti plavog jezika.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 14/03/2011.
Croatian: Datum prvog odobrenja: 14/03/2011
English: In order to avoid accidental contamination of the vaccine during use, it is recommended to use a multiinjection type vaccination system when larger dose presentations are used.
Croatian: Radi izbjegavanja slučajne kontaminacije cjepiva tijekom primjene većih doza, preporučuje se primjena sustava cijepljenja s višestrukim ubrizgavanjem.
English: Shake gently immediately before use.
Croatian: Lagano protresite neposredno prije primjene.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml of vaccine contains:
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Svaka doza od 2 ml cjepiva sadrži:
English: Primary vaccination: Administer one dose of 2 ml according to the following vaccination scheme:
Croatian: Primarno cijepljenje: Primijenite jednu dozu od 2 ml prema sljedećoj shemi cijepljenja:
English: Each dose of 2 ml of vaccine contains:
Croatian: Svaka doza od 2 ml cjepiva sadrži:
English: The safety and the efficacy of the vaccine have not been established in breeding males.
Croatian: Neškodljivost i djelotvornost cjepiva na rasplodnim mužjacima nije ustanovljena.
English: Disodium hydrogen phosphate dodecahydrate Sodium chloride
Croatian: Kalijev dihidrogenfosfat Dinatrijev hidrogenfosfat dodekahidrat Natrijev klorid
English: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by-case-basis.
Croatian: Odluku o primjeni ovog cjepiva prije, odnosno poslije primjene bilo kojeg drugog veterinarsko-medicinskog proizvoda treba donositi od slučaja do slučaja.
English: To stimulate active immunity against Bluetongue virus, serotypes 1 and 8 in sheep.
Croatian: Za stimulaciju aktivne imunosti protiv virusa bolesti plavog jezika, serotipova 1 i 8 kod ovaca.
English: In this category of animals the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against Bluetongue virus (BTV).
Croatian: U toj kategoriji životinja, cjepivo bi trebalo primjenjivati samo u skladu s procjenom odgovornog veterinara o odnosu koristi i rizika i/ili u skladu s odlukama nacionalnog nadležnog tijela o trenutačnim smjernicama cijepljenja protiv virusa bolesti plavog jezika (engl.
English: PACKAGE SIZE
Croatian: Veličine pakovanja
English: Lactation: No data is available on safety in lactating animals.
Croatian: Laktacija: Podaci o neškodljivosti prilikom primjene na životinjama u laktaciji nisu dostupni.
English: IMMUNOLOGICAL PROPERTIES
Croatian: FARMAKOLOŠKA IMUNOLOŠKA SVOJSTVA
English: EXPIRY DATE EXP {month/year} Once broached use immediately.
Croatian: EXP {mjesec/godina} Upotrijebiti neposredno nakon otvaranja.
English: PACKAGE LEAFLET: Zulvac 1+8 Ovis suspension for injection for sheep
Croatian: Zulvac 1+8 Ovis suspenzija za injekciju za ovce
English: Vaccination may be followed in most animals by a local reaction at the injection site.
Croatian: U većine životinja može doći do lokalne reakcije na mjestu ubrizgavanja.
English: THE WORDS “FOR ANIMAL TREATMENT ONLY” For animal treatment only.
Croatian: RIJEČI “SAMO ZA PRIMJENU NA ŽIVOTINJAMA“
English: 1348 Louvain-la-Neuve BELGIUM
Croatian: Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJA
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKI DJELATNIH TVARI I PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE U PROMET
English: Active immunisation of sheep from 1.5 months of age for the prevention* of viraemia caused by Bluetongue virus, serotypes 1 and 8.
Croatian: Aktivna imunizacija ovaca nakon navršenih 1,5 mjeseci starosti radi prevencije* viremije uzrokovane virusom bolesti plavog jezika, serotipova 1 i 8.
English: Administration of a two-fold overdose may be followed in most animals by a local reaction at the injection site.
Croatian: Nakon predoziranja dvostrukom dozom u većine životinja može doći do lokalne reakcije na mjestu ubrizgavanja.
English: A transient increase in rectal temperature, not exceeding 0.6 °C, may occur during the 24 hours following administration of a two-fold overdose.
Croatian: Tijekom 24 sata od predoziranja dvostrukom dozom može doći do prolaznog povišenja rektalne temperature, koje ne premašuje 0,6 °C.
English: No data are available on safety in lactating animals.
Croatian: Podaci o neškodljivosti za životinje u laktaciji nisu dostupni.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Vial label 100 ml and 240 ml
Croatian: PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKOVANJU Etiketa na bočici od 100 ml i 240 ml
English: These reactions take the form in most cases of a general swelling of the injection site (persisting for not more than 7 days) or of palpable nodules (subcutaneous granuloma possibly persisting for more than 48 days).
Croatian: U većini se slučajeva te reakcije manifestiraju kao otekline na mjestu ubrizgavanja (ne dulje od 7 dana) ili kao opipljivi čvorići (potkožni granulomi, mogu potrajati dulje od 48 dana).
English: These reactions take the form in most cases of a general swelling of the injection site (persisting for not more than 9 days) or of palpable nodules (subcutaneous granuloma, possibly persisting for more than 63 days).
Croatian: U većini slučajeva se te reakcije manifestiraju kao otekline na mjestu ubrizgavanja (ne dulje od 9 dana) ili kao opipljivi čvorići (potkožni granulomi, mogu potrajati dulje od 63 dana).
English: EU/2/11/120/002
Croatian: EU/2/11/120/002 EU/2/11/120/003
English: 1 bottle of 120 doses (240 ml).
Croatian: 1 bočica od 120 doza (240 ml).
English: STATEMENT OF ACTIVE SUBSTANCES Per dose of 2 ml:
Croatian: SASTAV DJELATNIH TVARI Po dozi od 2 ml:
English: Excipients: Thiomersal
Croatian: Pomoćne tvari: Tiomersal
English: A transient increase in rectal temperature, not exceeding 1.2 °C, may occur commonly during the 24 hours following vaccination.
Croatian: NUSPOJAVE Tijekom 24 sata od cijepljenja obično može doći do prolaznog povišenja rektalne temperature, koja ne premašuje 1,2 °C.
English: 1 bottle of 10 doses (20 ml).
Croatian: 1 bočica od 10 doza (20 ml).
English: Inactivated Bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
Croatian: Inaktivirani virus bolesti plavog jezika, serotip 8, soj BTV-8/BEL2006/02
English: 1 bottle of 50 doses (100 ml).
Croatian: 1 bočica od 50 doza (100 ml).
English: Zoetis Belgium SA Rue Laid Burniat 1
Croatian: Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJA
English: OTHER INFORMATION Pack sizes:
Croatian: 15. OSTALE INFORMACIJE Veličine pakovanja
English: WITHDRAWAL PERIOD(S) Zero days.
Croatian: Karencija(e): nula dana.
English: Pack of 1 bottle of 120 doses (240 ml).
Croatian: Pakiranje od 1 bočice s 120 doza (240 ml).
English: Pack of 1 bottle of 10 doses (20 ml).
Croatian: Pakiranje od 1 bočice s 10 doza (20 ml).
English: Pack of 1 bottle of 50 doses (100 ml).
Croatian: Pakiranje od 1 bočice s 50 doza (100 ml).
English: Active substance:
Croatian: Pomoćna tvar:
English: Once broached use immediately.
Croatian: Upotrijebiti neposredno nakon otvaranja.
English: 240 ml
Croatian: 100 ml 240 ml
English: Inactivated Bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1 Inactivated Bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
Croatian: Inaktivirani virus bolesti plavog jezika, serotip 1, soj BTV-1/ALG2006/01 E1 Inaktivirani virus bolesti plavog jezika, serotip 8, soj BTV- 8/BEL2006/02
English: Inactivated Bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1
Croatian: Djelatna tvar: Inaktivirani virus bolesti plavog jezika, serotip 1, soj BTV-1/ALG2006/01 E1
English: Aluminium hydroxide Saponin
Croatian: Aluminijev hidroksid, saponin, tiomersal.
English: If used in other domestic and wild ruminant species that are considered at risk of infection, its use in these species should be undertaken with care and it is advisable to test the vaccine on a small number of animals prior to mass vaccination.
Croatian: Preporučuje se testirati cjepivo na manjem broju životinja prije masovnog cijepljenja.
English: Special precautions for use in animals: Only use in healthy animals.
Croatian: Primijeniti samo na zdravim životinjama.
English: Ctra.
Croatian: Ovce.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/11/120/001-003
Croatian: EU/2/11/120/001 EU/2/11/120/002 EU/2/11/120/003
English: Pack sizes:
Croatian: UPUTA O VMP:
English: Special precautions for storage
Croatian: 6.4 Posebne mjere pri čuvanju
English: Do not stop taking Stalevo unless your doctor tells you to.
Croatian: Stalevo nemojte prestati uzimati osim ako Vam to ne kaže Vaš liječnik.
English: If you take more Stalevo than you should
Croatian: Ako uzmete više Staleva nego što ste trebali
English: Stalevo with food and drink
Croatian: Stalevo s hranom i pićem
English: For adults and elderly: - Your doctor will tell you exactly how many tablets of Stalevo to take each day.
Croatian: Odrasli i starije osobe: - Vaš liječnik će odrediti točno koliko tableta Staleva trebate uzeti svaki dan.
English: Stalevo may be taken with or without food.
Croatian: Stalevo se može uzimati sa ili bez hrane.
English: You should be aware that Stalevo may make these reactions worse.
Croatian: Morate biti svjesni da Stalevo te reakcije može pogoršati.
English: Stalevo should not be used during pregnancy unless the benefits for the mother outweigh the possible risks to the foetus.
Croatian: Stalevo se ne smije primjenjivati tijekom trudnoće, osim ako je korist za majku veća od mogućih rizika za fetus.
English: Experience with Stalevo in patients under 18 years is limited.
Croatian: Iskustvo sa Stalevom u bolesnika mlađih od 18 godina je ograničeno.
English: Therefore, do not take Stalevo and iron supplements at the same time.
Croatian: Stoga ne uzimajte istodobno Stalevo i preparate željeza.
English: Paediatric population: The safety and efficacy of Stalevo in children aged below 18 years have not been established.
Croatian: Pedijatrijska populacija: sigurnost i djelotvornost Staleva u djece mlađe od 18 godina nisu ustanovljene.
English: What Stalevo is and what it is used for
Croatian: Što je Stalevo i za što se koristi
English: Therefore, Stalevo and iron preparations should be taken at least 2-3 hours apart (see section 4.8).
Croatian: Stoga razmak između uzimanja Staleva i preparata željeza mora iznositi najmanje 2-3 sata (vidjeti dio 4.8).
English: Your doctor may take some regular laboratory tests during a long term treatment with Stalevo.
Croatian: Vaš će Vam liječnik možda napraviti neke redovite laboratorijske pretrage tijekom dugotrajnog liječenja Stalevom.
English: Other medicines and Stalevo
Croatian: Drugi lijekovi i Stalevo
English: Date of first authorisation: 17 October 2003 Date of latest renewal: 17 October 2008
Croatian: Datum posljednje obnove odobrenja: 17. listopada 2008.
English: It may therefore be necessary, particularly in patients with dyskinesia, to reduce levodopa dose by 10-30% within the first days to first weeks after initiating Stalevo treatment.
Croatian: Stoga može biti potrebno, posebno kod bolesnika s diskinezijom, smanjiti dozu levodope za 10-30% unutar prvih nekoliko dana ili tjedana po započinjanju liječenja Stalevom.
English: Therefore, the use of Stalevo in children or adolescents is not recommended.
Croatian: Stoga se primjena Staleva u djece ili adolescenata ne preporučuje.
English: The starting dose of Stalevo should provide either the same amount of levodopa or slightly (5-10%) more.
Croatian: Potrebno je započeti s doziranjem Staleva koje osigurava istu količinu levodope ili malo (5-10%) veću.
English: - All patients treated with Stalevo should be monitored carefully for the development of mental changes, depression with suicidal tendencies, and other serious antisocial behaviour.
Croatian: - Sve bolesnike liječene Stalevom treba pažljivo pratiti glede razvoja mentalnih promjena, depresije sa suicidalnim tendencijama i drugog teškog antisocijalnog ponašanja.
English: Pyridoxine, however, is not effective in reversing the actions of Stalevo.
Croatian: Piridoksin, međutim, nije učinkovit u suzbijanju djelovanja Staleva.
English: What Stalevo is and what it is used for What you need to know before you take Stalevo How to take Stalevo
Croatian: Što je Stalevo i za što se koristi Što morate znati prije nego počnete uzimati Stalevo Kako uzimati Stalevo
English: What you need to know before you take Stalevo
Croatian: Što morate znati prije nego počnete uzimati Stalevo
English: However, in an interaction study with healthy volunteers, entacapone did not change the plasma levels of S-warfarin, while the AUC for R-warfarin increased on average by 18% [CI90 1126%].
Croatian: Međutim, u jednom ispitivanju interakcija na zdravim dobrovoljcima, entakapon nije promijenio razine S-varfarina u plazmi, dok je AUC R-varfarina porastao prosječno za 18% [CI90 1126%].
English: Patients taking these medicinal products with Stalevo should be carefully observed for loss of therapeutic response.
Croatian: Bolesnike koji uzimaju ove lijekove sa Stalevom mora se pažljivo pratiti radi gubitka terapijskog odgovora.
English: If this happens, you should not drive or use any tools or machines (see also section 'Driving and using machines') - notice that uncontrolled movements begin or get worse after you started to take Stalevo.
Croatian: Ako se to dogodi, ne smijete voziti niti rukovati alatima ili strojevima (vidjeti također dio "Upravljanje vozilima i strojevima"), - primijetite pojavu nekontroliranih pokreta ili se oni pogoršaju nakon što počnete uzimati Stalevo.
English: When used with Stalevo, the daily dose of selegiline should not exceed 10 mg.
Croatian: Kada se primijenjuje sa Stalevom, dnevna doza selegilina ne smije prijeći 10 mg.
English: Talk to your doctor or pharmacist if you think the effect of Stalevo is too strong or too weak, or if you experience possible side effects.
Croatian: Razgovarajte sa svojim liječnikom ili ljekarnikom ako mislite da je učinak Staleva prejak ili preslab ili ako doživite moguće nuspojave.
English: Stalevo is used for the treatment of Parkinson's disease.
Croatian: Stalevo se koristi za liječenje Parkinsonove bolesti.
English: If therapy has to be stopped temporarily, Stalevo may be restarted as soon as oral medicinal products can be taken at the same daily dose as before.
Croatian: Ako terapiju treba privremeno obustaviti, primjena Staleva može se ponovno započeti čim se mogu uzimati oralni lijekovi uz isto dnevno doziranje kao i prije.
English: Do not take Stalevo if you are taking certain medicines for treating depression (combinations of selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).
Croatian: Ne uzimajte Stalevo ako uzimate određene lijekove za liječenje depresije (kombinaciju selektivnih MAO-A i MAO-B inhibitora, ili neselektivne MAO inhibitore).
English: However, caution should be exercised when these medicinal products are used concomitantly with Stalevo (see sections 4.3 and 4.4).
Croatian: Međutim, kada se ovi lijekovi koriste istodobno sa Stalevom potreban je oprez (vidjeti dijelove 4.3 i 4.4).
English: - Stalevo may induce orthostatic hypotension.
Croatian: - Stalevo može izazvati ortostatsku hipotenziju.
English: At the initiation, Stalevo should be adjusted to correspond as closely as possible to the total daily dose of levodopa currently used.
Croatian: Na početku se mora prilagoditi doza Staleva da bi ona bila što je moguće bliža ukupnoj dnevnoj dozi levodope koja se trenutno koristi.
English: Stalevo may lower your blood pressure, which may make you feel light-headed or dizzy.
Croatian: Stalevo može sniziti krvni tlak, zbog čega možete osjetiti ošamućenost ili omaglicu.